Literature DB >> 11170974

Systemic cidofovir in papillomatosis.

I Van Valckenborgh1, W Wellens, K De Boeck, R Snoeck, E De Clercq, L Feenstra.   

Abstract

An 8-year-old patient with severe recurrent respiratory papillomatosis and pulmonary spread was treated by systemic administration of cidofovir in association with laser treatment for tracheal lesions. Complete disappearance of the lesions in the pharynx and larynx and a significant yet incomplete regression in the bronchi and lung parenchyma were observed without deleterious side effects. This is the first case report of systemic use of cidofovir to treat recurrent respiratory papillomatosis.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11170974     DOI： 10.1086/318497

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  4 in total

Review 1.  Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.

Authors:  Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 2.  Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.

Authors:  Ferdinand I Broekema; Frederik G Dikkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-06       Impact factor: 2.503

3.  A Case of the Intrapulmonary Spread of Recurrent Respiratory Papillomatosis With Malignant Transformation.

Authors:  Yang Xiao; Jun Wang; Demin Han; Lijing Ma
Journal:  Am J Med Sci       Date:  2015-07       Impact factor: 2.378

Review 4.  Ear, nose and throat manifestation of viral systemic infections in pediatric patients.

Authors:  N Mansi; V de Maio; A della Volpe; G Ripa; L Malafronte; C de Filippis
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-12       Impact factor: 1.675
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.